Jan-Erik Frodin
Overview
Explore the profile of Jan-Erik Frodin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kinos S, Hagman H, Halonen P, Soveri L, OReilly M, Pfeiffer P, et al.
Acta Oncol
. 2024 May;
63:248-258.
PMID: 38698698
Background And Purpose: The CardioSwitch-study demonstrated that patients with solid tumors who develop cardiotoxicity on capecitabine or 5-fluorouracil (5-FU) treatment can be safely switched to S-1, an alternative fluoropyrimidine (FP)....
2.
Helgadottir H, Matikas A, Fernebro J, Frodin J, Ekman S, Rodriguez-Wallberg K
Eur J Cancer
. 2024 Mar;
202:114010.
PMID: 38520926
The treatment landscape of solid tumors has changed markedly in the last years. Molecularly targeted treatments and immunotherapies have been implemented and have, in many cancers, lowered the risk of...
3.
Ghanipour L, Palmer G, Nilsson P, Nordenvall C, Frodin J, Bexe Lindskog E, et al.
PLoS One
. 2024 Mar;
19(3):e0294018.
PMID: 38437211
Standard treatment for patient with peritoneal metastases from colorectal cancer is cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). In recent years, the efficacy of oxaliplatin-based HIPEC has been challenged....
4.
Pedone C, Sorcini B, Staff C, Farlin J, Fokstuen T, Frodin J, et al.
Clin Transl Radiat Oncol
. 2022 Dec;
39:100562.
PMID: 36582423
Background And Purpose: Neoadjuvant short-course radiotherapy (SCRT) followed by full-dose systemic chemotherapy is an established treatment modality in locally advanced rectal cancer (LARC). Until recently, SCRT has been exclusively delivered...
5.
Karimi M, Osterlund P, Hammarstrom K, Imam I, Frodin J, Glimelius B
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551723
Complete pathological response (pCR) is achieved in 10−20% of rectal cancers when treated with short-course radiotherapy (scRT) or long-course chemoradiotherapy (CRT) and in 28% with total neoadjuvant therapy (scRT/CRT +...
6.
Erlandsson J, Fuentes S, Radu C, Frodin J, Johansson H, Brandberg Y, et al.
BJS Open
. 2022 Jan;
5(6).
PMID: 35040942
Background: The Stockholm III trial randomly assigned 840 patients to short-course radiotherapy of 5 × 5 Gy with surgery within 1 week (SRT), short-course radiotherapy of 5 × 5 Gy...
7.
Kettis A, Fagerlind H, Frodin J, Glimelius B, Ring L
J Patient Rep Outcomes
. 2021 Jul;
5(1):58.
PMID: 34259966
Background: Effective patient-physician communication can improve patient understanding, agreement on treatment and adherence. This may, in turn, impact on clinical outcomes and patient quality of life (QoL). One way to...
8.
Ullenhag G, Frodin J, Jeddi-Tehrani M, Lidstromer N, Strigard K, Eriksson E, et al.
Clin Cancer Res
. 2019 May;
25(9):2939.
PMID: 31043387
No abstract available.
9.
Karimi M, von Salome J, Aravidis C, Silander G, Askmalm M, Henriksson I, et al.
Hered Cancer Clin Pract
. 2018 Nov;
16:16.
PMID: 30386444
Background: Lynch Syndrome is an autosomal dominant cancer syndrome caused by pathogenic germ-line variants in one of the DNA-mismatch-repair (MMR) genes or . Carriers are predisposed to colorectal and endometrial...
10.
Buchli C, Martling A, Abani M, Frodin J, Bottai M, Lax I, et al.
Ann Surg
. 2016 Nov;
267(2):326-331.
PMID: 27849668
Objective: The aim of this study was to assess the acute effect of preoperative RT for rectal cancer on endocrine testicular function. Background: Preoperative radiotherapy (RT) enhances local control and...